Monkeypox: what we know and what we need to learn 2022

Content from UpNext.com.au. Please don't scrape website.

Monkeypox (MPX) has arrived in Australia, and strategies are urgently needed to curb its spread. While Australia has secured some third-generation smallpox vaccine, supply issues mean urgent consideration is needed as to how the vaccine is best distributed. And with men who have sex with men currently the most at risk group for MPX, non-stigmatising and community-led prevention programs will be crucial.

Please join us for a special webinar on MPX where we consider the history of the epidemic, how it may impact Australia, and how research can help. Collaborative, rigorous and timely research can uncover pragmatic solutions to the challenges posed by MPX, and there are many lessons that can be applied from the HIV and COVID-19 pandemics.

Professor Raina MacIntyre is on the WHO SAGE smallpox and MPX working group, and will give an overview of the prevention and treatment of orthopoxviruses. Professor Andrew Grulich, a leader in Australia's response to HIV, will provide a description of the current epidemic in Australia and the available public health responses. They will be joined by Mr Heath Paynter from AFAO who will talk about the community response to MPX in Australia.